SCHEMBL2291992

SCHEMBL2291992

CCN1c2ccccc2Nc2c(CC(=O)O)cccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.39
GAA P10253 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TSPO P30536 3/20 0.38
PTGS2 P35354 2/20 0.36
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
KMT2A Q03164 2/20 0.34
CYP19A1 P11511 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
PPARG P37231 4/20 0.34
PLA2G2A P14555 1/20 0.34
BRD4 O60885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3413314 0.84 LTB4R (0.40) GAASMN1; SMN2
Sulfuric Acid SCHEMBL29282027 0.82 GAA (0.36) GAASMN1; SMN2TSPOKMT2AMEN1
SCHEMBL2292527 0.81 ALOX5 (0.48) GAASMN1; SMN2TDP1TSPOKMT2A
SCHEMBL2292134 0.75 S1PR5 (0.41) SMN1; SMN2TDP1KMT2AMEN1PLA2G2A
SCHEMBL17187689 0.75 CYP2C19 (0.46) GAASMN1; SMN2KMT2AKDM4E
SCHEMBL2291776 0.75 MAPK1 (0.41) GAASMN1; SMN2TSPOKDM4EBRD4
SCHEMBL2287889 0.74 GAA (0.48) GAASMN1; SMN2TDP1TSPOKMT2A
SCHEMBL2289464 0.74 TSPO (0.35) GAASMN1; SMN2TSPOKMT2AKDM4E
SCHEMBL8376596 0.71 DRD2 (0.39) KMT2AKDM4EMEN1
Sulfuric Acid SCHEMBL10339576 0.71 ALDH1A1 (0.38) GAASMN1; SMN2TDP1TSPOKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265726-B1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY ROCHE DIAGNOSTICS GMBH (DE) 2014-05-07 EP disclosed
US-8535511-B2 Methods for electrochemical analysis using matrix compositions with alkylphenazine quaternary salt and a nitrosoaniline ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2013-09-17 US disclosed
US-8008037-B2 Matrix composition with alkylphenazine quaternary salt and a nitrosoaniline ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2011-08-30 US disclosed
EP-2265726-A1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY Roche Diagnostics GmbH (DE) 2010-12-29 EP disclosed
WO-2009118157-A1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY ROCHE DIAGNOSTICS GMBH (DE) 2009-10-01 WO disclosed
US-20090246808-A1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY ROCHE DIABETES CARE, INC. 2009-10-01 US disclosed